Tampa-based Osceola Capital has created its eighth platform in its Osceola Fund I, the firm’s flagship institutional fund, with an eye on taking advantage of opportunities in the pharmacy business.
Last June, Osceola Fund I closed at its hard cap of $125 million. Attracting capital from global public pension plans, financial institutions, a university endowment, family offices and several high-net-worth investors.
The new platform, Revelation Pharma Corp., was founded in partnership with industry . . .
Unlock this article instantly, along with the rest of our premium content and daily, weekly and monthly newsletters. We offer pay-as-you-go monthly subscriptions and discounted annual subscriptions with additional benefits: access to Alternatives Watch Research articles and our Annual Investor Compendium.